T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Western Union
WU
$2.34B
| $194M | 0.02% |
13,905,891
+13,724,584
| +7,570% | +$177M |
|
|
RNAM
427
DELISTED
Avidity Biosciences
RNAM
| $190M | 0.02% |
7,429,107
+516,446
| +7% | +$8.09M |
|
428
Crown Castle
CCI
$32.2B
| $189M | 0.02% |
1,783,020
+95,711
| +6% | +$10.4M |
|
429
Assurant
AIZ
$13.9B
| $187M | 0.02% |
992,640
-38,615
| -4% | -$6.73M |
|
430
Veralto
VLTO
$23.8B
| $186M | 0.02% |
2,100,025
-2,226,811
| -51% | -$185M |
|
431
Armstrong World Industries
AWI
$7.68B
| $186M | 0.02% |
1,494,963
-91,588
| -6% | -$10.1M |
|
432
Verra Mobility
VRRM
$731M
| $185M | 0.02% |
7,427,527
+351,694
| +5% | +$8M |
|
433
Zegna
ZGN
$3.73B
| $184M | 0.02% |
12,558,622
-246,676
| -2% | -$3.19M |
|
434
Equinor
EQNR
$96.3B
| $183M | 0.02% |
6,783,338
+6,507,511
| +2,359% | +$178M |
|
435
Biohaven
BHVN
$2.24B
| $183M | 0.02% |
3,347,022
+212,699
| +7% | +$10.5M |
|
436
Gilead Sciences
GILD
$171B
| $183M | 0.02% |
2,492,514
-328,986
| -12% | -$25.3M |
|
437
Capital One
COF
$137B
| $181M | 0.02% |
1,214,929
+292,978
| +32% | +$39.7M |
|
438
Roblox
RBLX
$27.1B
| $181M | 0.02% |
4,737,657
+65,191
| +1% | +$2.65M |
|
439
Tyler Technologies
TYL
$13.5B
| $181M | 0.02% |
424,982
+65,814
| +18% | +$28.1M |
|
440
Arvinas
ARVN
$589M
| $180M | 0.02% |
4,368,418
+536,295
| +14% | +$23.4M |
|
441
Eaton
ETN
$176B
| $180M | 0.02% |
576,657
+8,153
| +1% | +$2.23M |
|
442
Crinetics Pharmaceuticals
CRNX
$8.96B
| $179M | 0.02% |
3,823,218
+814,360
| +27% | +$31.9M |
|
443
Vornado Realty Trust
VNO
$7.41B
| $178M | 0.02% |
6,196,145
+44,147
| +0.7% | +$1.18M |
|
444
IDEAYA Biosciences
IDYA
$3.53B
| $178M | 0.02% |
4,052,500
+486,222
| +14% | +$20.9M |
|
445
Blackstone
BX
$112B
| $177M | 0.02% |
1,345,005
+383,827
| +40% | +$47.9M |
|
446
Newmont
NEM
$120B
| $176M | 0.02% |
4,907,101
+313,736
| +7% | +$10.8M |
|
447
Ero Copper
ERO
$3.58B
| $176M | 0.02% |
9,108,705
-5,773,963
| -39% | -$95.2M |
|
448
EastGroup Properties
EGP
$11B
| $175M | 0.02% |
975,450
+71,614
| +8% | +$12.9M |
|
449
Voya Financial
VOYA
$9.16B
| $175M | 0.02% |
2,368,185
+2,156,773
| +1,020% | +$152M |
|
450
Gen Digital
GEN
$17.7B
| $175M | 0.02% |
7,798,918
+1,038,415
| +15% | +$23M |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.